Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse

被引:36
作者
Dalton, GL
Lee, MD
Kennett, GA
Dourish, CT
Clifton, PG [1 ]
机构
[1] Univ Sussex, Dept Psychol, Brighton BN1 9QG, E Sussex, England
[2] Vernalis Res Ltd, Woking RG41 5UA, Surrey, England
[3] Univ British Columbia, Sch Med, Dept Psychiat, Vancouver, BC V6T 1Z4, Canada
[4] Univ Coll Swansea, Dept Psychol, Swansea SA2 8PP, W Glam, Wales
基金
英国生物技术与生命科学研究理事会;
关键词
5-HT2C receptor; 5HT(1B) receptor; mCPP; CP-94,253; feeding; hyperactivity;
D O I
10.1007/s00213-005-0212-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: This study was conducted to examine the functional relationship between 5-HT1B receptors (5-HT1B-R) and 5-HT2C receptors (5-HT2C-R) in the control of food intake. Objectives: The aim of this study was to compare the hypophagic effect of the 5-HT2C/1B-R agonist m-chlorophenylpiperazine (mCPP) with that of the selective 5-HT1B-R agonist CP-94,253 in both wild-type (WT) and 5-HT2C knockout (KO) mice. Methods: The hypophagic effects of mCPP (1, 3 and 5.6 mg/kg) and CP-94,253 (5, 10 and 20 mg/kg) were assessed in WT and 5-HT2C KO mice using the behavioural satiety sequence paradigm. The effects of pretreatment with the selective 5-HT2C-R antagonist SB 242,084 (0.5 and 1.5 mg/kg) were assessed in WT mice given mCPP or CP-94,253. Results: The 5-HT2C/1B receptor agonist mCPP and the selective 5-HT1B receptor agonist CP-94,253 both suppressed food intake in WT mice. 5-HT2C KO mice were insensitive to the hypophagic effects of mCPP but were more sensitive to CP-94,253-induced hypophagia than WT controls. mCPP induced a significant increase in postprandial activity in 5-HT2C KO mice but this effect was absent in 5-HT2C KO mice given CP-94,253. Data from WT mice pretreated with the 5-HT2C receptor antagonist SB 242,084 and then challenged with either mCPP or CP-94,253 were similar to those obtained from 5-HT2C KO mice. Conclusions: 5-HT2C-R and 5-HT1B-R activation are each sufficient to induce a hypophagic response. However, concurrent 5-HT2C-R inactivation can potentiate the hypophagic response to 5-HT1B-R activation, consistent with an inhibitory role for the 5-HT2C-R in behaviour mediated by activation of other 5-HT receptors. These results also confirm that 5-HT1B-R activation alone cannot account for the hyperactive response of 5-HT2C KO mice to mCPP.
引用
收藏
页码:45 / 57
页数:13
相关论文
共 45 条
[1]   CHOLECYSTOKININ ELICITS COMPLETE BEHAVIORAL SEQUENCE OF SATIETY IN RATS [J].
ANTIN, J ;
GIBBS, J ;
HOLT, J ;
YOUNG, RC ;
SMITH, GP .
JOURNAL OF COMPARATIVE AND PHYSIOLOGICAL PSYCHOLOGY, 1975, 89 (07) :784-790
[2]   INTRAVENOUS ADMINISTRATION OF THE SEROTONIN AGONIST M-CHLOROPHENYLPIPERAZINE (MCPP) INCREASES EXTRACELLULAR SEROTONIN IN THE DIENCEPHALON OF AWAKE RATS [J].
BAUMANN, MH ;
RUTTER, JJ ;
AUERBACH, SB .
NEUROPHARMACOLOGY, 1993, 32 (12) :1381-1386
[3]   THE ROLE OF PUTATIVE 5-HT1A AND 5-HT1B RECEPTORS IN THE CONTROL OF FEEDING IN RATS [J].
BENDOTTI, C ;
SAMANIN, R .
LIFE SCIENCES, 1987, 41 (05) :635-642
[4]  
BLUNDELL JE, 1977, INT J OBESITY, V1, P15
[5]   MOLECULAR-BIOLOGY OF 5-HT RECEPTORS [J].
BOESS, FG ;
MARTIN, IL .
NEUROPHARMACOLOGY, 1994, 33 (3-4) :275-317
[6]   Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist, and d-fenfluramine on feeding patterns in the rat [J].
Clifton, PG ;
Lee, MD ;
Dourish, CT .
PSYCHOPHARMACOLOGY, 2000, 152 (03) :256-267
[7]   5-HT1B receptor knockout mice show a compensatory reduction in 5-HT2C receptor function [J].
Clifton, PG ;
Lee, MD ;
Somerville, EM ;
Kennett, GA ;
Dourish, CT .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 17 (01) :185-190
[8]  
CLIFTON PG, 1994, ETHOLOGY AND PSYCHOPHARMACOLOGY, P313
[9]   MCPP-induced hyperactivity in 5-HT2c receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes [J].
Dalton, GL ;
Lee, MD ;
Kennett, GA ;
Dourish, CT ;
Clifton, PG .
NEUROPHARMACOLOGY, 2004, 46 (05) :663-671
[10]   Effects of serotonin 5-HT1/2 receptor agonists in a limited-access operant food intake paradigm in the rat [J].
De Vry, J ;
Schreiber, R ;
Daschke, A ;
Jentzsch, KR .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 (05) :337-345